U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07943312) titled 'GA001 Injection in Retinitis Pigmentosa' on Nov. 02.

Brief Summary: This Phase II clinical trial evaluates the safety, tolerability, and efficacy of GA001 Injection in patients with retinitis pigmentosa.

Study Start Date: April 01, 2027

Study Type: INTERVENTIONAL

Condition: Retinitis Pigmentosa (RP)

Intervention: GENETIC: GA001

Single unilateral IVT injection of GA001 Injection in the study eye

PROCEDURE: Sham injection

Sham IVT procedure in the study eye

Recruitment Status: NOT_YET_RECRUITING

Sponsor: GenAns Biotechnology Co., Ltd

Published by HT Digital Content Services with permission from Health Daily Digest....